Improving The Success Rate in IVF Process Using Mothers Own Blood Fluid
Not Applicable
- Conditions
- Health Condition 1: O029- Abnormal product of conception, unspecifiedHealth Condition 2: O038- Other and unspecified complications following complete or unspecified spontaneous abortion
- Registration Number
- CTRI/2022/07/043718
- Lead Sponsor
- STEMBIONICS PVT LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
At least one implantation failure in IVF.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pregnancy positiveTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method 1.Observation of implanted zygote <br/ ><br>2.Qualitative analysis of implanted zygote <br/ ><br>Timepoint: 3 months